Tuesday, March 17, 2026

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

North Korea’s Drone Claims: What Does It Mean for South Korea’s Security in 2026?

Tensions between North and South Korea rise over drone accusations, but de-escalation seems possible with ongoing investigations.

KOSPI Crisis: Why South Korea’s Stock Market Plummeted to 4900—What You Need to Know

South Korean stock market faces a sharp decline, with KOSPI and KOSDAQ indexes dropping significantly amid foreign selling pressures.

Tag: humanitarian

No posts to display

Top News

- Our Sponsors Ad -

Follow us